Tianli Hui
No. 169 Tianshan Street
Shijiazhuang, 050035, China
Shijiazhuang, 050035, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Updated survival outcomes of SYHX2011 versus albumin-bound paclitaxel in advanced breast cancer: A randomized double-blind phase III trial.
Journal: Biomolecules & biomedicine
Published: April 23, 2026
Albumin-Bound Paclitaxel (SYHX2011) in Patients with Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Phase III Study.
Journal: Cancer communications (London, England)
Published: December 09, 2025
Prognostic value of RecurIndex in differentiating HER2-low from HER2-negative early-stage breast cancer: a comprehensive clinicopathologic and molecular analysis in Chinese patients.
Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: August 22, 2025
Integrative single-cell and bulk RNA-seq analysis identifies glycosyltransferases-related signature in triple negative breast cancer.
Journal: Functional & integrative genomics
Published: June 24, 2025
Elevated HIF-1α levels in maintenance hemodialysis patients: a potential link to increased cognitive impairment risk.
Journal: Frontiers in aging neuroscience
Published: July 18, 2024
An Analysis of Clinical and Pathologic Features, RecurIndex Genomic Profiles, and Survival Outcomes in HER2-Low Breast Cancer.
Journal: The oncologist
Published: December 29, 2022
Pegylated liposomal doxorubicin-induced hand-foot syndrome predicted by serum metabolomic profiling and prevented by calcium dobesilate.
Journal: Journal of the American Academy of Dermatology
Published: December 21, 2020
Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus.
Journal: Scientific reports
Published: December 14, 2020
Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052).
Journal: Scientific reports
Published: July 19, 2019
Impact of next-generation sequencing (NGS) for primary endocrine resistance in breast cancer patients.
Journal: International journal of clinical and experimental pathology
Published: August 15, 2018
Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer.
Journal: Oncotarget
Published: December 07, 2016
Last Updated: 09/26/2026